Use of metamizole in children and the risk of agranulocytosis: Is the benefit worth the risk?

Rollason, Victoria; Desmeules, Jules Alexandre

doi:10.1097/EJA.0000000000000275

Scientific article

English

Use of metamizole in children and the risk of agranulocytosis: Is the benefit worth the risk?

ContributorsRollason, Victoria; Desmeules, Jules Alexandre

Published inEuropean journal of anaesthesiology, vol. 32, no. 12, p. 837-838

Publication date2015

Affiliation entities

Faculté des sciences / Section des sciences pharmaceutiques
Faculté de médecine / Section de médecine clinique / Département d'anesthésiologie, pharmacologie, soins intensifs et urgences

Research groups

Groupe Desmeules Jules (pharmacologie/toxicologie) (567)

Citation (ISO format)

ROLLASON, Victoria, DESMEULES, Jules Alexandre. Use of metamizole in children and the risk of agranulocytosis: Is the benefit worth the risk? In: European journal of anaesthesiology, 2015, vol. 32, n° 12, p. 837–838. doi: 10.1097/EJA.0000000000000275

Article (Published version)

Identifiers

PID : unige:78729
DOI : 10.1097/EJA.0000000000000275
PMID : 26509242

Journal ISSN0265-0215

539views

4downloads

Creation11/12/2015 15:24:00

First validation11/12/2015 15:24:00

Update time14/03/2023 23:59:10

Status update14/03/2023 23:59:10

Last indexation31/10/2024 02:19:10

Archive ouverte UNIGE

Use of metamizole in children and the risk of agranulocytosis: Is the benefit worth the risk?

Technical informations